NCT07540884 Evaluation of Tears Naturale® Free and Tears Naturale® II Lubricant Eye Drops
| NCT ID | NCT07540884 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Alcon Research |
| Condition | Dry Eye Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2026-06-04 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2026-06-04 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this post-market clinical follow-up (PMCF) study is to describe the effectiveness and safety of Tears Naturale® Free and Tears Naturale® II lubricant eye drops in subjects experiencing dry eye (DE) symptoms.
Eligibility Criteria
Key Inclusion Criteria: * Able to read, understand, and sign an Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved informed consent form in English or French. * Able to attend all study visits as required as per protocol. * Mild to moderate dry eye disease. * Willing to discontinue use of all habitual artificial tear supplements and use only the study device for the entire study duration. * Other protocol-defined inclusion criteria may apply. Key Exclusion Criteria: * Any known allergic reactions to the study products or its ingredients. * Ocular injury to either eye in the past 3 months prior to screening. * Ocular surgery within the previous 6 months or ocular surgery planned during the study. * Use of any systemic medication known to cause dry eye for less than 1 month before the Screening/Baseline visit. * Other protocol-defined exclusion criteria may apply.
Contact & Investigator
Clinical Trial Lead, Dry Eye
STUDY DIRECTOR
Alcon Research, LLC
Frequently Asked Questions
Who can join the NCT07540884 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dry Eye Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07540884 currently recruiting?
Yes, NCT07540884 is actively recruiting participants. Contact the research team at alcon.medinfo@alcon.com for enrollment information.
Where is the NCT07540884 trial being conducted?
This trial is being conducted at Burnaby, Canada, Kelowna, Canada, North York, Canada, Toronto, Canada and 2 additional locations.
Who is sponsoring the NCT07540884 clinical trial?
NCT07540884 is sponsored by Alcon Research. The principal investigator is Clinical Trial Lead, Dry Eye at Alcon Research, LLC. The trial plans to enroll 120 participants.